Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like and HER2 intrinsic subtypes of breast cancer

(2013) S D Soysal et al.   BRITISH JOURNAL OF CANCER

Establishment and Validation of Circulating Tumor Cell-Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients

(2013) A. Giordano et al.   CLINICAL CANCER RESEARCH

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

(2013) Sandra M Swain et al.   LANCET ONCOLOGY

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer

(2012) Markus Wallwiener et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

(2012) François-Clément Bidard et al.   CANCER AND METASTASIS REVIEWS

Prognostic Value of Circulating Tumor Cells According to Immunohistochemically Defined Molecular Subtypes in Advanced Breast Cancer

(2012) Elisabetta Munzone et al.   Clinical Breast Cancer

Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer

(2012) L. Zhang et al.   CLINICAL CANCER RESEARCH

Invasive lobular carcinoma predicts micrometastasis in breast cancer

(2012) Sarah M. Gainer et al.   JOURNAL OF SURGICAL RESEARCH

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

(2011) J.- Y. Pierga et al.   ANNALS OF ONCOLOGY

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy

(2011) A. Giordano et al.   ANNALS OF ONCOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients

(2011) Antonio Giordano et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

(2010) F.- C. Bidard et al.   ANNALS OF ONCOLOGY

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer

(2009) Edoardo Botteri et al.   BREAST CANCER RESEARCH AND TREATMENT

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer

(2009) I Van der Auwera et al.   BRITISH JOURNAL OF CANCER

Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma

(2009) Anne Vincent-Salomon et al.   EUROPEAN JOURNAL OF CANCER

Re: Anti–Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

(2009) Steven J. Van Laere et al.   JNCI-Journal of the National Cancer Institute

Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

(2008) Anieta M. Sieuwerts et al.   JNCI-Journal of the National Cancer Institute